Cardiometabolic Comorbidities in Patients With Psoriasis: Focusing on Risk, Biological Therapy, and Pathogenesis
Psoriasis is a chronic inflammatory disease characterized by erythematous scaly plaques, accompanied by systemic damage that leads to the development of multiple comorbidities. In particular, the association between psoriasis and cardiometabolic comorbidities, including cardiovascular diseases (CVDs...
Guardado en:
Autores principales: | Jiangluyi Cai, Lian Cui, Yu Wang, Ying Li, Xilin Zhang, Yuling Shi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/29eef2a332c8487a99e5fcd26e4944c8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparison of Behavioral Risk Factors and Cardiometabolic Comorbidities of Psoriatic Arthritis and Psoriasis: A Case–Control Study in Chinese Patients
por: Wang Q, et al.
Publicado: (2021) -
Psoriasis and Cardiometabolic Diseases: The Impact of Inflammation on Vascular Health
por: Teklu M, et al.
Publicado: (2021) -
Integrating lifestyle-focused approaches into psoriasis care: improving patient outcomes?
por: Landriscina A, et al.
Publicado: (2016) -
Metabolic Syndrome and Psoriasis: A Case–Control Study in Kabul, Afghanistan
por: Aalemi AK, et al.
Publicado: (2021) -
Psoriasis
por: MOLL LEE,NORMAN
Publicado: (1947)